Medscape

Better 5-Year Valve Performance With TAVI Than Surgery

In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...
Medscape

DAPT After Transcatheter Valve-in-Valve Implantation? The Debate Continues

Transcatheter aortic valve implantation (TAVI) has been touted for “revolutionizing the field of cardiology,” as the preferred treatment for most patients over age 70 years with severe aortic stenosis ...
TCTMD

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

ORLANDO, FL—(UPDATED) Through 5 years, TAVI with a self-expanding valve provided clinical outcomes similar to those seen with surgery in an intermediate-risk population, according to continued ...
TCTMD

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
Business Wire

Thubrikar Aortic Valve announces initial 30-day outcomes of CE Mark-enabling TAVI-1 Study

NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™).
The New England Journal of Medicine

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking ...